UBS Group’s Novelion Therapeutics Inc. Common Shares NVLN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-3,823
| Closed | -$3K | – | 7512 |
|
|
2019
Q3 | $3K | Buy |
3,823
+2,157
| +129% | +$1.69K | ﹤0.01% | 6733 |
|
|
2019
Q2 | $1K | Sell |
1,666
-4,482
| -73% | -$2.69K | ﹤0.01% | 6922 |
|
|
2019
Q1 | $8K | Buy |
6,148
+5,641
| +1,113% | +$7.34K | ﹤0.01% | 6145 |
|
|
2018
Q4 | $0 | Sell |
507
-5,914
| -92% | – | ﹤0.01% | 7394 |
|
|
2018
Q3 | $19K | Buy |
6,421
+4,464
| +228% | +$13.2K | ﹤0.01% | 5924 |
|
|
2018
Q2 | $7K | Buy |
1,957
+1,930
| +7,148% | +$6.9K | ﹤0.01% | 6446 |
|
|
2018
Q1 | $0 | Sell |
27
-697
| -96% | – | ﹤0.01% | 7227 |
|
|
2017
Q4 | $2K | Buy |
724
+188
| +35% | +$519 | ﹤0.01% | 6679 |
|
|
2017
Q3 | $4K | Buy |
536
+509
| +1,885% | +$3.8K | ﹤0.01% | 6426 |
|
|
2017
Q2 | $0 | Sell |
27
-774
| -97% | – | ﹤0.01% | 7016 |
|
|
2017
Q1 | $8K | Sell |
801
-925
| -54% | -$9.24K | ﹤0.01% | 5848 |
|
|
2016
Q4 | $14K | Buy |
+1,726
| New | +$14K | ﹤0.01% | 5787 |
|